David Low, a professor in UCSB’s Department of Molecular, Cellular, and Developmental Biology, has announced he will pursue an innovative global health and development research project, “Strategy for development of enteric pathogen-specific phage”. Low’s research intends to focus on a new way to deal with major bacterial pathogens that are becoming resistant to a handful of once-powerful antibiotics. According to Investec CEO Kenny Slaught, “He will engineer phage to selectively target and destroy several pathogenic bacteria to prevent enteric diseases in infants”.